A nationwide shortage of a chemotherapy drug that is a mainstay of treatment for several cancers, including testicular cancer ...

Many chemo drugs are ototoxic which means they can cause hearing loss. This provides information on some of the drugs and resoruces which can help the chemo patient. The world is getting fainter and ...

Chemotherapy is one of the most common weapons in the cancer-treatment arsenal, but its side effects are well known. Hair loss. Nausea and vomiting. Mouth sores. Fatigue. The side effects a person ...

Enhertu isn’t a typical chemotherapy or immunotherapy drug but rather a combination of chemotherapy and targeted therapy, known as an antibody-drug conjugate. Enhertu works by using an antibody to ...

Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Stream Connecticut News for free, 24/7, wherever you are. Drugmakers have poured billions of dollars into ...

Oncologists across India have raised serious concerns over a shortage of two critical chemotherapy drugs — Cisplatin and Carboplatin — warning that disruptions in supply could affect treatment for ...

In a new research report, scientists at Johns Hopkins University School of Medicine and Johns Hopkins Kimmel Cancer Center ...

Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline drugs by 77% in the first randomized ...

Researchers have used a new gold-based drug to slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a new study. A new gold-based drug ...

Keytruda is not chemotherapy. It’s a type of treatment called immunotherapy. It works with the body’s immune system, helping T cells fight cancer cells. With immunotherapy, the body’s immune system ...

But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects in some cases. Antibody-drug conjugates ...